Importantly, expression of endosialin is dramatically reduced in adults, but has been shown to be up-regulated during pathologic states, including tumor progression and metastasis [4, 5] making endosialin an oncofetal protein with potential as therapeutic target [6, 7]. The gene discussed is CD248; the disease is neoplasm.